Screener
Merit Medical Systems MMSI Single Reportable — Sales & Marketing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Merit Medical Systems in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: Merit Medical Systems’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:23 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000856982-26-000025
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Net sales | $381,877 | $355,351 |
| Cost of sales standard(1) | 147,017 | 142,803 |
| Cost of sales other(2) | 50,063 | 40,528 |
| Selling and marketing expenses | 73,957 | 64,929 |
| General and administrative expenses | 44,253 | 42,557 |
| Research and development expenses | 22,609 | 22,478 |
| Other operating expenses(3) | (179) | 1,023 |
| Other (income) expense — net | (9,389) | 3,075 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Merit Medical Systems's single reportable — sales & marketing?
- Merit Medical Systems (MMSI) reported single reportable — sales & marketing of $73.96M in Q1 2026.
- What does single reportable — sales & marketing mean?
- This metric tracks the costs incurred for sales commissions, advertising, and promotional activities dedicated to the segment's product portfolio. It provides insight into the company's investment in customer acquisition and brand positioning within the competitive medical device market. High levels of this expense relative to revenue may indicate aggressive growth strategies or increased competitive pressure.
Ask your AI about Merit Medical Systems's single reportable — sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude